305 Results

People

  1. Seidman
    Seidman
  2. Aghajanian
    Aghajanian
  3. De Angelis
    De Angelis
  4. Hudis
    Hudis
  5. Kelsen
    Kelsen
  6. Lichtman
    Lichtman
  7. Saltz
    Saltz
  8. Scher
    Scher
  9. Bajorin
    Bajorin
  10. Fornier
    Fornier

Groups

  1. Department of Medicine (206)
  2. Solid Tumor Oncology Division (153)
  3. Survivorship Research (59)
  4. Hematologic Malignancies, Division of (51)
  5. Center for Hematologic Malignancies (47)
  6. Breast Medicine Service (43)
  7. Gastrointestinal Oncology Service (37)
  8. Surgery (29)
  9. Genitourinary Oncology Service (28)
  10. Center for Pancreatic Cancer Research (26)
  1. "peripheral neuropathy"
Formats
  1. Journal Article (283)
  2. Review (10)
  3. Conference Paper (6)
  4. Correspondence (3)
  5. Book Section (2)
  6. Guidelines (1)
Groups
  1. Department of Medicine (206)
  2. Solid Tumor Oncology Division (153)
  3. Survivorship Research (59)
  4. Hematologic Malignancies, Division of (51)
  5. Center for Hematologic Malignancies (47)
  6. Breast Medicine Service (43)

More Groups

People
  1. Andrew Seidman (16)
  2. Carol Aghajanian (12)
  3. Lisa De Angelis (12)
  4. Clifford Hudis (10)
  5. David Kelsen (10)
  6. Howard Scher (10)

More People

Years
  1. 2025 (9)
  2. 2024 (15)
  3. 2023 (19)
  4. 2022 (11)
  5. 2021 (7)
  6. 2020 (10)

More Years

Publications
  1. Journal of Clinical Oncology (26)
  2. Gynecologic Oncology (15)
  3. Lancet Oncology (14)
  4. Cancer (10)
  5. Annals of Oncology (9)
  6. Clinical Cancer Research (9)

More Publications

Publishers
  1. Elsevier Inc. (56)
  2. American Society of Clinical Oncology (26)
  3. Elsevier Science, Inc. (25)
  4. Springer (20)
  5. Wiley Blackwell (17)
  6. Oxford University Press (15)

More Publishers

Results (305)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Potential mediators of oxaliplatin-induced peripheral neuropathy from adjuvant therapy in stage III colon cancer: Findings from CALGB (Alliance)/SWOG 80702
    Journal Article

    Lee, S.; Ma, C.; Shi, Q.; Kumar, P.; Couture, F.; Kuebler, P.; Krishnamurthi, S.; Lewis, D.; Tan, B.; Goldberg, R. M.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Impact of baseline expectancy on outcome prediction of real and sham acupuncture for persistent chemotherapy-induced peripheral neuropathy pain in solid tumor survivors: A secondary analysis of a randomized clinical trial
    Journal Article

    Li, X.; Zhi, L.; Han, K. Y.; Li, S. Q.; Ahmad, K.; Seluzicki, C.; Wang, R.; Bao, T.
    Integrative Cancer Therapies (2023)

    Fulltext@MSK | Save
  • A review of immune checkpoint blockade for the general surgeon
    Review

    Baldwin, X. L.; Spanheimer, P. M.; Downs-Canner, S.
    Journal of Surgical Research (2023)

    Fulltext@MSK | Save
  • Identifying participants’ preferences for modifiable chemotherapy-induced peripheral neuropathy prevention clinical trial factors: An adaptive choice-based conjoint analysis
    Journal Article

    Knoerl, R.; Berry, D.; Meyerhardt, J. A.; Reyes, K.; Salehi, E.; Thornton, K.; Gewandter, J. S.
    Supportive Care in Cancer (2022)

    Fulltext@MSK | Save
  • Stereotactic magnetic resonance-guided adaptive radiation therapy (SMART) for abdominopelvic oligometastases
    Journal Article

    Yang, D. D.; Brennan, V. S.; Huynh, E.; Williams, C. L.; Han, Z.; Ampofo, N.; Vastola, M. E.; Sangal, P.; Singer, L.; Mak, R. H.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • Abnormal photoplethysmography waveforms are associated with chemotherapy induced neuropathy
    Journal Article

    Bryce, Y.; Santos-Martin, E.; Ziv, E.; Gonzalez-Aguirre, A.; Moussa, A.; Friedman, A.; Maybody, M.
    Vasa - European Journal of Vascular Medicine (2022)

    Fulltext@MSK | Save
  • Triplet therapy, transplantation, and maintenance until progression in myeloma
    Journal Article

    Richardson, P. G.; Jacobus, S. J.; Weller, E. A.; Hassoun, H.; Lonial, S.; Raje, N. S.; Medvedova, E.; McCarthy, P. L.; Libby, E. N.; Voorhees, P. M.; more...
    New England Journal of Medicine (2022)

    Fulltext@MSK | Save
  • Sotigalimab and/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: Clinical and immunologic analyses from the randomized phase 2 PRINCE trial
    Journal Article

    Padrón, L. J.; Maurer, D. M.; O’Hara, M. H.; O’Reilly, E. M.; Wolff, R. A.; Wainberg, Z. A.; Ko, A. H.; Fisher, G.; Rahma, O.; Lyman, J. P.; more...
    Nature Medicine (2022)

    Fulltext@MSK | Save
  • Older patients (aged ≥60 years) with previously untreated advanced-stage classical Hodgkin lymphoma: A detailed analysis from the phase III ECHELON-1 study
    Journal Article

    Evens, A. M.; Connors, J. M.; Younes, A.; Ansell, S. M.; Kim, W. S.; Radford, J.; Feldman, T.; Tuscano, J.; Savage, K. J.; Oki, Y.; more...
    Haematologica (2022)

    Fulltext@MSK | Save
  • Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): Final analysis of a randomised, open-label, phase 3 study
    Journal Article

    Diaz, L. A. Jr; Shiu, K. K.; Kim, T. W.; Jensen, B. V.; Jensen, L. H.; Punt, C.; Smith, D.; Garcia-Carbonero, R.; Benavides, M.; Gibbs, P.; more...
    Lancet Oncology (2022)

    Fulltext@MSK | Save